Reuters logo
Pfizer to buy Hospira for about $15 bln
February 5, 2015 / 12:11 PM / 3 years ago

Pfizer to buy Hospira for about $15 bln

Feb 5 (Reuters) - Drugmaker Pfizer Inc said it would buy Hospira Inc for about $15 billion to gain access to its biosimilars.

The offer of $90 per share represents a premium of 39 percent to Hospira stock’s close on Wednesday.

The total enterprise value of the deal is about $17 billion, the companies said. (Reporting by Vidya L Nathan in Bengaluru; Editing by Don Sebastian)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below